Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 907

1.

NMR Relaxation Dispersion Reveals Macrocycle Breathing Dynamics in a Cyclodextrin-based Rotaxane.

Stoffel S, Zhang QW, Li DH, Smith BD, Peng JW.

J Am Chem Soc. 2020 Mar 26. doi: 10.1021/jacs.9b12524. [Epub ahead of print]

PMID:
32212648
2.

The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing.

Dalton WB, Helmenstine E, Pieterse L, Li B, Gocke CD, Donaldson J, Xiao Z, Gondek LP, Ghiaur G, Gojo I, Smith BD, Levis MJ, DeZern AE.

Blood Adv. 2020 Apr 14;4(7):1192-1196. doi: 10.1182/bloodadvances.2019001127. No abstract available.

PMID:
32211880
3.

Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer.

Bagley AF, Anscher MS, Choi S, Frank SJ, Hoffman KE, Kuban DA, McGuire SE, Nguyen QN, Chapin B, Aparicio A, Pezzi TA, Smith GL, Smith BD, Hess K, Tang C.

JAMA Netw Open. 2020 Mar 2;3(3):e201255. doi: 10.1001/jamanetworkopen.2020.1255.

4.

Overcoming microenvironment-mediated protection from ATRA using CYP26-resistant retinoids.

Hernandez D, Palau L, Norsworthy K, Anders NM, Alonso S, Su M, Petkovich M, Chandraratna R, Rudek MA, Smith BD, Jones RJ, Ghiaur G.

Leukemia. 2020 Mar 9. doi: 10.1038/s41375-020-0790-4. [Epub ahead of print] No abstract available.

PMID:
32152463
5.

Age at Diagnosis and Patient Preferences for Treatment Outcomes in AML: A Discrete Choice Experiment to Explore Meaningful Benefits.

Richardson D, Crossnohere NL, Seo J, Estey E, O'Donoghue B, Smith BDD, Bridges JF.

Cancer Epidemiol Biomarkers Prev. 2020 Mar 4. pii: cebp.1277.2019. doi: 10.1158/1055-9965.EPI-19-1277. [Epub ahead of print]

PMID:
32132149
6.

A Multidisciplinary Consensus Recommendation on a Synoptic Radiation Treatment Summary: A Commission on Cancer Workgroup Report.

Christodouleas JP, Anderson N, Gabriel P, Greene R, Hahn C, Kessler S, Mayo CS, McNutt T, Shulman LN, Smith BD, West J, Williamson T.

Pract Radiat Oncol. 2020 Jan 24. pii: S1879-8500(20)30002-3. doi: 10.1016/j.prro.2020.01.002. [Epub ahead of print]

PMID:
31988040
7.

ASO Author Reflections: Impact of Surgical Subspecialization in Breast Cancer-The Case for Fellowship Training.

Diao K, Smith BD.

Ann Surg Oncol. 2020 Apr;27(4):1023-1024. doi: 10.1245/s10434-020-08214-1. Epub 2020 Jan 21. No abstract available.

PMID:
31965367
8.

Dual-Targeted Phototherapeutic Agents as Magic Bullets for Cancer.

Wen Y, Schreiber CL, Smith BD.

Bioconjug Chem. 2020 Mar 18;31(3):474-482. doi: 10.1021/acs.bioconjchem.9b00836. Epub 2020 Jan 23.

PMID:
31940166
9.

Effect of Surgeon Factors on Long-Term Patient-Reported Outcomes After Breast-Conserving Therapy in Older Breast Cancer Survivors.

Smith BD, Lei X, Diao K, Xu Y, Shen Y, Smith GL, Giordano SH, DeSnyder SM, Hunt KK, Teshome M, Jagsi R, Shaitelman SF, Peterson SK, Swanick CW.

Ann Surg Oncol. 2020 Apr;27(4):1013-1022. doi: 10.1245/s10434-019-08165-2. Epub 2020 Jan 8.

PMID:
31916092
10.

The Charge to Liberate Siloed Radiation Oncology Treatment Data Through Uniform and Structured Documentation: A Commentary on American Society for Radiation Oncology and Commission on Cancer Recommendations.

Grant SR, Smith BD, Mayo CS.

Pract Radiat Oncol. 2019 Nov 29. pii: S1879-8500(19)30336-4. doi: 10.1016/j.prro.2019.11.009. [Epub ahead of print] No abstract available.

PMID:
31790824
11.

Paired Agent Fluorescence Imaging of Cancer in a Living Mouse Using Preassembled Squaraine Molecular Probes with Emission Wavelengths of 690 and 830 nm.

Schreiber CL, Zhai C, Dempsey JM, McGarraugh HH, Matthews BP, Christmann CR, Smith BD.

Bioconjug Chem. 2020 Feb 19;31(2):214-223. doi: 10.1021/acs.bioconjchem.9b00750. Epub 2019 Dec 6.

PMID:
31756298
12.

Maculopathy in Patients with Monoclonal Gammopathy of Undetermined Significance.

Smith SJ, Johnson MW, Ober MD, Comer GM, Smith BD.

Ophthalmol Retina. 2020 Mar;4(3):300-309. doi: 10.1016/j.oret.2019.09.018. Epub 2019 Oct 9.

PMID:
31753810
13.

Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials.

Ludmir EB, Subbiah IM, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mandel JJ, Fang P, Smith BD, Smith GL, Pinnix CC, Sedrak MS, Kimmick GG, Stinchcombe TE, Jagsi R, Thomas CR Jr, Fuller CD, VanderWalde NA.

J Geriatr Oncol. 2020 Apr;11(3):451-454. doi: 10.1016/j.jgo.2019.11.001. Epub 2019 Nov 8.

PMID:
31711757
14.

Examinations in Radiation Oncology: Listening, Learning, and Looking Forward Together.

Ennis RD, Movsas B, Park C, Sandler HM, Smith BD, Wilson L, Deweese TL.

Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):29-31. doi: 10.1016/j.ijrobp.2019.10.012. Epub 2019 Oct 21. No abstract available.

PMID:
31647971
15.

Sea Change: A Decade of Intensity-Modulated Radiation Therapy for Treatment of Breast Cancer.

Smith GL, Smith BD.

J Natl Cancer Inst. 2020 Mar 1;112(3):221-223. doi: 10.1093/jnci/djz199. No abstract available.

PMID:
31647554
16.

"Après Mois, Le Déluge": Preparing for the Coming Data Flood in the MRI-Guided Radiotherapy Era.

Kiser KJ, Smith BD, Wang J, Fuller CD.

Front Oncol. 2019 Sep 30;9:983. doi: 10.3389/fonc.2019.00983. eCollection 2019. Review.

17.

High affinity threading of a new tetralactam macrocycle in water by fluorescent deep-red and near-infrared squaraine dyes.

Dempsey JM, Zhai C, McGarraugh HH, Schreiber CL, Stoffel SE, Johnson A, Smith BD.

Chem Commun (Camb). 2019 Nov 4;55(85):12793-12796. doi: 10.1039/c9cc05244e. Epub 2019 Oct 8.

PMID:
31593200
18.

Croconaine Rotaxane Dye with 984 nm Absorption: Wavelength-Selective Photothermal Heating.

McGarraugh HH, Liu W, Matthews BP, Smith BD.

European J Org Chem. 2019 Jun 10;2019(21):3489-3494. doi: 10.1002/ejoc.201900082. Epub 2019 Feb 18.

PMID:
31579392
19.

A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic Transplantation.

Pratz KW, Rudek MA, Smith BD, Karp J, Gojo I, Dezern A, Jones RJ, Greer J, Gocke C, Baer MR, Duong VH, Rosner G, Zahurak M, Wright JJ, Emadi A, Levis M; ETCTN-8922 study team.

Biol Blood Marrow Transplant. 2020 Feb;26(2):300-306. doi: 10.1016/j.bbmt.2019.09.023. Epub 2019 Sep 21.

20.

Epilogue: Treatment Plan.

Bagley AF, Smith BD.

Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):475-476. doi: 10.1016/j.ijrobp.2019.08.046. No abstract available.

PMID:
31540594
21.

Radiated, Reconstructed, Recurred.

Bagley AF, Smith BD.

Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):471-472. doi: 10.1016/j.ijrobp.2019.05.070. No abstract available.

PMID:
31540590
22.

Minimum Data Elements for Radiation Oncology: An American Society for Radiation Oncology Consensus Paper.

Hayman JA, Dekker A, Feng M, Keole SR, McNutt TR, Machtay M, Martin NE, Mayo CS, Pawlicki T, Smith BD, Kudner R, Dawes S, Yu JB.

Pract Radiat Oncol. 2019 Nov;9(6):395-401. doi: 10.1016/j.prro.2019.07.017. Epub 2019 Aug 21. Review.

PMID:
31445187
23.

Anatomically Optimizing Reirradiation.

Augustyn A, Smith BD.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):19. doi: 10.1016/j.ijrobp.2018.09.036. No abstract available.

PMID:
31422806
24.

Sex-Based Disparities Among Cancer Clinical Trial Participants.

Ludmir EB, Fuller CD, Moningi S, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Verma V, Smith BD, Smith GL, VanderWalde NA, Holliday EB, Guadagnolo BA, Stinchcombe TE, Jagsi R, Gomez DR, Minsky BD, Rödel C, Fokas E.

J Natl Cancer Inst. 2020 Feb 1;112(2):211-213. doi: 10.1093/jnci/djz154.

PMID:
31350545
25.

Neoadjuvant Radiotherapy to Facilitate Immediate Breast Reconstruction: A Systematic Review and Current Clinical Trials.

Singh P, Hoffman K, Schaverien MV, Krause KJ, Butler C, Smith BD, Kuerer HM.

Ann Surg Oncol. 2019 Oct;26(10):3312-3320. doi: 10.1245/s10434-019-07538-x. Epub 2019 Jul 24.

PMID:
31342362
26.

Patient Selection for Clinical Trials Eliminating Surgery for HER2-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy.

Sun S, van la Parra RFD, Rauch GM, Checka C, Tadros AB, Lucci A Jr, Teshome M, Black D, Hwang RF, Smith BD, Krishnamurthy S, Valero V, Yang WT, Kuerer HM.

Ann Surg Oncol. 2019 Oct;26(10):3071-3079. doi: 10.1245/s10434-019-07533-2. Epub 2019 Jul 24.

PMID:
31342361
27.

Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction.

Hambley BC, Norsworthy KJ, Jasem J, Zimmerman JW, Shenderov E, Webster JA, Showel MM, Gondek LP, Dalton WB, Prince G, Gladstone DE, Streiff MB, Pratz KW, Gojo I, Ghiaur G, Levis MJ, Smith BD, DeZern AE.

Leuk Res. 2019 Aug;83:106174. doi: 10.1016/j.leukres.2019.106174. Epub 2019 Jun 21. No abstract available.

PMID:
31255938
28.

Breast cancer and aging: Standing on the shoulders of a giant.

Karuturi MS, Sedrak MS, Magnuson A, Freedman R, Jatoi A, Smith BD, Kimmick GG.

J Geriatr Oncol. 2020 Mar;11(2):212-216. doi: 10.1016/j.jgo.2019.05.019. Epub 2019 Jun 11. Review.

PMID:
31201096
29.

Side effects from acute myeloid leukemia treatment: results from a national survey.

Crossnohere NL, Richardson DR, Reinhart C, O'Donoghue B, Love SM, Smith BD, Bridges JFP.

Curr Med Res Opin. 2019 Nov;35(11):1965-1970. doi: 10.1080/03007995.2019.1631149. Epub 2019 Jun 26.

PMID:
31188058
30.

Molecular recognition using tetralactam macrocycles with parallel aromatic sidewalls.

Li DH, Smith BD.

Beilstein J Org Chem. 2019 May 9;15:1086-1095. doi: 10.3762/bjoc.15.105. eCollection 2019. Review.

31.

Factors Associated With Age Disparities Among Cancer Clinical Trial Participants.

Ludmir EB, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Mandel JJ, Lin SH, Smith BD, Smith GL, VanderWalde NA, Minsky BD, Koong AC, Stinchcombe TE, Jagsi R, Gomez DR, Thomas CR Jr, Fuller CD.

JAMA Oncol. 2019 Jun 3. doi: 10.1001/jamaoncol.2019.2055. [Epub ahead of print]

PMID:
31158272
32.

Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants.

Smith BD, Kaufman MD, Lu WP, Gupta A, Leary CB, Wise SC, Rutkoski TJ, Ahn YM, Al-Ani G, Bulfer SL, Caldwell TM, Chun L, Ensinger CL, Hood MM, McKinley A, Patt WC, Ruiz-Soto R, Su Y, Telikepalli H, Town A, Turner BA, Vogeti L, Vogeti S, Yates K, Janku F, Abdul Razak AR, Rosen O, Heinrich MC, Flynn DL.

Cancer Cell. 2019 May 13;35(5):738-751.e9. doi: 10.1016/j.ccell.2019.04.006.

PMID:
31085175
33.

Long-term decision regret surrounding systemic therapy in older breast cancer survivors: A population-based survey study.

Karuturi MS, Lei X, Shen Y, Giordano SH, Swanick CW, Smith BD.

J Geriatr Oncol. 2019 Nov;10(6):973-979. doi: 10.1016/j.jgo.2019.03.013. Epub 2019 Mar 30.

PMID:
30940493
34.

Time-lapse imaging of cell death in cell culture and whole living organisms using turn-on deep-red fluorescent probes.

Jarvis TS, Roland FM, Dubiak KM, Huber PW, Smith BD.

J Mater Chem B. 2018 Aug 14;6(30):4963-4971. doi: 10.1039/C8TB01495G. Epub 2018 Jul 10.

35.

Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement.

Christopherson K, Lei X, Barcenas C, Buchholz TA, Garg N, Hoffman KE, Kuerer HM, Mittendorf E, Perkins G, Shaitelman SF, Smith GL, Stauder M, Strom EA, Tereffe W, Woodward WA, Smith BD.

Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):574-581. doi: 10.1016/j.ijrobp.2019.02.049. Epub 2019 Mar 6.

PMID:
30851348
36.

Trends in Radiation for Bone Metastasis During a Period of Multiple National Quality Improvement Initiatives.

Logan JK, Jiang J, Shih YT, Lei X, Xu Y, Hoffman KE, Giordano SH, Smith BD.

J Oncol Pract. 2019 Apr;15(4):e356-e368. doi: 10.1200/JOP.18.00588. Epub 2019 Mar 8.

37.

Stabilization and Extraction of Fluoride Anion Using a Tetralactam Receptor.

Liu W, Oliver AG, Smith BD.

J Org Chem. 2019 Apr 5;84(7):4050-4057. doi: 10.1021/acs.joc.9b00042. Epub 2019 Mar 12.

PMID:
30827107
38.

Nucleophilic addition of phosphorus(iii) derivatives to squaraines: colorimetric detection of transition metal-mediated or thermal reversion.

Bacher EP, Lepore AJ, Pena-Romero D, Smith BD, Ashfeld BL.

Chem Commun (Camb). 2019 Mar 18;55(22):3286-3289. doi: 10.1039/c9cc01243e. Epub 2019 Feb 27.

39.

Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation.

Mohamed ASR, Smith BD, Smith JB, Sevak P, Malek JS, Kanwar A, Browne T, Gunn GB, Garden AS, Frank SJ, Morrison WH, Phan J, Zafereo M, Skinner H, Lai SY, Hutcheson KA, Lewin JS, Hessel AE, Thekdi AA, Weber RS, Fuller CD, Rosenthal DI.

Laryngoscope. 2020 Jan;130(1):146-153. doi: 10.1002/lary.27873. Epub 2019 Feb 12.

PMID:
30756394
40.

Y2O3 optical constants between 5 nm and 50 nm.

Muhlestein JB, Smith BD, Miles M, Thomas SM, Willey A, Allred DD, Turley RS.

Opt Express. 2019 Feb 4;27(3):3324-3336. doi: 10.1364/OE.27.003324.

PMID:
30732355
41.

Shape-Selective Recognition of Quaternary Ammonium Chloride Ion Pairs.

Li DH, Smith BD.

J Org Chem. 2019 Mar 1;84(5):2808-2816. doi: 10.1021/acs.joc.8b03197. Epub 2019 Feb 15.

PMID:
30730144
42.

Local Therapy Decisional Regret in Older Women With Breast Cancer: A Population-Based Study.

Advani PG, Lei X, Swanick CW, Xu Y, Shen Y, Goodwin NA, Smith GL, Giordano SH, Hunt KK, Jagsi R, Smith BD.

Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):383-391. doi: 10.1016/j.ijrobp.2019.01.089. Epub 2019 Feb 1.

PMID:
30716524
43.

The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.

Webster J, Smith BD.

Clin Ther. 2019 Feb;41(2):336-349. doi: 10.1016/j.clinthera.2018.12.013. Epub 2019 Jan 30. Review.

44.

Implementing an Electronic Data Capture System to Improve Clinical Workflow in a Large Academic Radiation Oncology Practice.

Pasalic D, Reddy JP, Edwards T, Pan HY, Smith BD.

JCO Clin Cancer Inform. 2018 Dec;2:1-12. doi: 10.1200/CCI.18.00034.

45.

Ancient DNA reveals the timing and persistence of organellar genetic bottlenecks over 3,000 years of sunflower domestication and improvement.

Wales N, Akman M, Watson RHB, Sánchez Barreiro F, Smith BD, Gremillion KJ, Gilbert MTP, Blackman BK.

Evol Appl. 2018 Feb 13;12(1):38-53. doi: 10.1111/eva.12594. eCollection 2019 Jan.

46.

Do Internal Mammary Nodes Matter?

Caudle AS, Smith BD.

Ann Surg Oncol. 2019 Apr;26(4):930-932. doi: 10.1245/s10434-018-07152-3. Epub 2019 Jan 7. No abstract available.

47.

Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide.

McCurdy SR, Kanakry CG, Tsai HL, Gojo I, Smith BD, Gladstone DE, Bolaños-Meade J, Borrello I, Matsui WH, Swinnen LJ, Huff CA, Brodsky RA, Ambinder RF, Fuchs EJ, Rosner GL, Jones RJ, Luznik L.

Biol Blood Marrow Transplant. 2019 Jun;25(6):1128-1135. doi: 10.1016/j.bbmt.2018.12.767. Epub 2018 Dec 30.

48.

Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome.

Cortes JE, Heidel FH, Hellmann A, Fiedler W, Smith BD, Robak T, Montesinos P, Pollyea DA, DesJardins P, Ottmann O, Ma WW, Shaik MN, Laird AD, Zeremski M, O'Connell A, Chan G, Heuser M.

Leukemia. 2019 Feb;33(2):379-389. doi: 10.1038/s41375-018-0312-9. Epub 2018 Dec 16.

49.

New tetralactam hosts for squaraine dyes.

Dempsey JM, Zhang QW, Oliver AG, Smith BD.

Org Biomol Chem. 2018 Nov 28;16(46):8976-8983. doi: 10.1039/c8ob02596g.

50.

Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial.

Shaitelman SF, Lei X, Thompson A, Schlembach P, Bloom ES, Arzu IY, Buchholz D, Chronowski G, Dvorak T, Grade E, Hoffman K, Perkins G, Reed VK, Shah SJ, Stauder MC, Strom EA, Tereffe W, Woodward WA, Amaya DN, Shen Y, Hortobagyi GN, Hunt KK, Buchholz TA, Smith BD.

J Clin Oncol. 2018 Oct 31:JCO1800317. doi: 10.1200/JCO.18.00317. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center